Literature DB >> 23712652

Temporal profile of diabetic nephropathy pathologic changes.

Cecilia Ponchiardi1, Michael Mauer, Behzad Najafian.   

Abstract

Diabetic nephropathy, by far, is the most common cause of end stage renal disease in the US and many other countries. In type 1 diabetes, the natural history of diabetic nephropathy is tightly linked to evolution of classic lesions of the disease, namely glomerular basement membrane thickening, increased mesangial matrix, and reduced glomerular filtration surface density. These lesions progress in parallel and correlate with increased albumin excretion rate and reduced glomerular filtration rate across a wide range of renal function. In fact, the vast majority of the variances of albumin excretion and glomerular filtration rates can be explained by these glomerular lesions alone in type 1 diabetic patients. Although, classic lesions of diabetic nephropathy, indistinguishable from those of type 1 diabetes, also occur in type 2 diabetes, renal lesions are more heterogeneous in type 2 diabetic patients with some patients developing more advanced vascular or chronic tubulointerstitial lesions than diabetic glomerulopathy. More research biopsy longitudinal studies, especially in type 2 diabetic patients, are needed to better understand various pathways of renal injury in diabetic nephropathy.

Entities:  

Mesh:

Year:  2013        PMID: 23712652     DOI: 10.1007/s11892-013-0395-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  46 in total

1.  Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies.

Authors:  Gianna Mazzucco; Tullio Bertani; Mirella Fortunato; Monica Bernardi; Monica Leutner; Renzo Boldorini; Guido Monga
Journal:  Am J Kidney Dis       Date:  2002-04       Impact factor: 8.860

2.  Podocyte number in normotensive type 1 diabetic patients with albuminuria.

Authors:  Kathryn E White; Rudolf W Bilous; Sally M Marshall; Meguid El Nahas; Giuseppe Remuzzi; Giampiero Piras; Salvatore De Cosmo; GianCarlo Viberti
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

3.  Podocytes are sensitive to fluid shear stress in vitro.

Authors:  Colin Friedrich; Nicole Endlich; Wilhelm Kriz; Karlhans Endlich
Journal:  Am J Physiol Renal Physiol       Date:  2006-05-09

4.  Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes.

Authors:  M Luiza Caramori; Youngki Kim; Chunmei Huang; Alfred J Fish; Stephen S Rich; Michael E Miller; Greg Russell; Michael Mauer
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy.

Authors:  R Osterby; G Nyberg
Journal:  J Diabet Complications       Date:  1987 Oct-Dec

6.  Podocyte detachment in type 2 diabetic nephropathy.

Authors:  E Jennifer Weil; Kevin V Lemley; Berne Yee; Tracy Lovato; Meghan Richardson; Bryan D Myers; Robert G Nelson
Journal:  Am J Nephrol       Date:  2011-06-10       Impact factor: 3.754

7.  Urinary excretion of podocytes in patients with diabetic nephropathy.

Authors:  T Nakamura; C Ushiyama; S Suzuki; M Hara; N Shimada; I Ebihara; H Koide
Journal:  Nephrol Dial Transplant       Date:  2000-09       Impact factor: 5.992

8.  Proximal tubular basement membrane width in insulin-dependent diabetes mellitus.

Authors:  P L Brito; P Fioretto; K Drummond; Y Kim; M W Steffes; J M Basgen; S Sisson-Ross; M Mauer
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

9.  Pathologic classification of diabetic nephropathy.

Authors:  Thijs W Cohen Tervaert; Antien L Mooyaart; Kerstin Amann; Arthur H Cohen; H Terence Cook; Cinthia B Drachenberg; Franco Ferrario; Agnes B Fogo; Mark Haas; Emile de Heer; Kensuke Joh; Laure H Noël; Jai Radhakrishnan; Surya V Seshan; Ingeborg M Bajema; Jan A Bruijn
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

10.  Studies of kidney and muscle biopsy specimens from identical twins discordant for type I diabetes mellitus.

Authors:  M W Steffes; D E Sutherland; F C Goetz; S S Rich; S M Mauer
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

View more
  20 in total

1.  Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy.

Authors:  Ze-Bo Hu; Kun-Ling Ma; Yang Zhang; Gui-Hua Wang; Liang Liu; Jian Lu; Pei-Pei Chen; Chen-Chen Lu; Bi-Cheng Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

Review 2.  Podocytes: the Weakest Link in Diabetic Kidney Disease?

Authors:  Jamie S Lin; Katalin Susztak
Journal:  Curr Diab Rep       Date:  2016-05       Impact factor: 4.810

3.  Distinct roles of arginases 1 and 2 in diabetic nephropathy.

Authors:  Sidney M Morris; Hanning You; Ting Gao; Jean Vacher; Timothy K Cooper; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-26

Review 4.  Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

Authors:  Caroline B Marshall
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

5.  TGR5 suppresses high glucose-induced upregulation of fibronectin and transforming growth factor-β1 in rat glomerular mesangial cells by inhibiting RhoA/ROCK signaling.

Authors:  Fengxiao Xiong; Xuejuan Li; Zhiying Yang; Yu Wang; Wenyan Gong; Junying Huang; Cheng Chen; Peiqing Liu; Heqing Huang
Journal:  Endocrine       Date:  2016-07-28       Impact factor: 3.633

Review 6.  B cells in type 1 diabetes mellitus and diabetic kidney disease.

Authors:  Mia J Smith; Kimber M Simmons; John C Cambier
Journal:  Nat Rev Nephrol       Date:  2017-10-17       Impact factor: 28.314

7.  SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway.

Authors:  Jin-Lan Xu; Xin-Xin Gan; Jun Ni; De-Cui Shao; Yang Shen; Nai-Jun Miao; Dan Xu; Li Zhou; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2018-05-10       Impact factor: 6.150

8.  Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models.

Authors:  Qun Wang; Ya Shi; Zengguang Wu; Xinli Song; Jinfang Luo; Hong Yang; Xiaolan Chen; Xingde Liu
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

Review 9.  Molecular mechanisms of diabetic kidney disease.

Authors:  Kimberly Reidy; Hyun Mi Kang; Thomas Hostetter; Katalin Susztak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

10.  Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.

Authors:  Lili Zhang; Lin Han; Xinmiao Wang; Yu Wei; Jinghui Zheng; Linhua Zhao; Xiaolin Tong
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.